C. Palomo

发表

Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment.

J. Skehel, M. Begoña Ruiz-Argüello, L. González-Reyes, 2002, Virology.

Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics

P. Rottier, C. Palomo, J. Melero, 2015, PloS one.

Generation of monoclonal antibodies specific of the postfusion conformation of the Pneumovirinae fusion (F) protein

C. Palomo, J. Melero, V. Más, 2015, Journal of Virological Methods.

COMPOUNDS TARGETED AGAINST THE FUSION (F) GLYCOPROTEIN 3

P. Gómez-Puertas, C. Palomo, J. Melero, 2010 .

Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein

P. Gómez-Puertas, C. Palomo, J. Melero, 2010, Journal of Virology.

A Monomeric Uncleaved Respiratory Syncytial Virus F Antigen Retains Prefusion-Specific Neutralizing Epitopes

P. Dormitzer, A. Carfi, C. Palomo, 2014, Journal of Virology.

The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies.

C. Palomo, B. García-Barreno, J. Melero, 1995, Viral immunology.

The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years

C. Palomo, J. Melero, M. González‐Sánchez, 2017, Front. Microbiol..

Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses

C. Palomo, J. Melero, G. Taylor, 2016, Journal of Virology.

Note on the activation of the heme-stabilized translational inhibitor of reticulocyte lysates by oxidized glutathione.

J. M. Sierra, C. Palomo, 1988, Biochimie.

Intragroup antigenic diversity of human respiratory syncytial virus (group A) isolated in Argentina and Chile

M. Galiano, C. Palomo, L. Avendaño, 2005, Journal of medical virology.

Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

C. Palomo, B. García-Barreno, J. Melero, 2005, Journal of medical virology.

Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.

C. Palomo, B. García-Barreno, J. Melero, 2004, Vaccine.

Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides.

M. Galiano, C. Palomo, B. García-Barreno, 2003, The Journal of general virology.

Prevalence of anti‐human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population

C. Palomo, B. García-Barreno, J. Melero, 2003, Journal of medical virology.

Evaluation of the antibody specificities of human convalescent‐phase sera against the attachment (G) protein of human respiratory syncytial virus: Influence of strain variation and carbohydrate side chains

P. Cane, C. Palomo, J. Melero, 2000, Journal of medical virology.

The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.

C. Palomo, B. García-Barreno, J. Melero, 1991, The Journal of general virology.

Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

C. Palomo, B. García-Barreno, J. Melero, 1989, Journal of virology.

Studies on the activation of the heme-stabilized translational inhibitor of reticulocyte lysates by oxidized glutathione and NADPH depletion.

J. M. Sierra, S. Ochoa, Ó. Vicente, 1985, Archives of biochemistry and biophysics.

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

C. Palomo, J. Melero, P. Piedra, 2015, Antimicrobial Agents and Chemotherapy.

Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies

C. Palomo, B. García-Barreno, J. Melero, 1990, Journal of virology.

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

C. Palomo, J. Melero, D. Luque, 2012, Proceedings of the National Academy of Sciences.

Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection

C. Palomo, J. Melero, L. Detalle, 2016, Antimicrobial Agents and Chemotherapy.

Natural spleen cell ligandome in transporter antigen processing (TAP)-deficient mice.

Eilon Barnea, A. Admon, C. Palomo, 2019, Journal of proteome research.

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence

Eilon Barnea, A. Admon, C. Palomo, 2019, PLoS neglected tropical diseases.

Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells.

Eilon Barnea, A. Admon, C. Palomo, 2019, Journal of proteome research.

Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.

C. Palomo, J. Melero, L. Calder, 2014, Virology.

Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins

J. McLellan, C. Hsieh, C. Palomo, 2022, Nature Communications.

Genetic and Antigenic Variability of Human Respiratory Syncytial Virus (Groups A and B) Isolated over Seven Consecutive Seasons in Argentina (1995 to 2001)

M. Galiano, C. Palomo, J. Melero, 2005, Journal of Clinical Microbiology.

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

U. Baxa, B. Graham, Syed M. Moin, 2015, PLoS pathogens.

Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation

J. McLellan, C. Palomo, J. Melero, 2016, PLoS pathogens.

, Seasons in Argentina ( 1995 to 2001 ) B ) Isolated over Seven Consecutive Respiratory Syncytial Virus ( Groups A and Genetic and Antigenic Variability of Human

M. Galiano, C. Palomo, J. Melero, 2005 .

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.

L. Gutshall, C. Palomo, J. Melero, 2007, The Journal of general virology.